BRAINAURORA-B (06681) announced that the company recently entered into a strategic cooperation agreement with Natural Health Solutions Programme Group Holdings (Natural Health Solutions). The two parties will collaborate on product promotion and market expansion in Singapore, jointly driving the development of the digital health industry. Singapore, as one of Asia's developed economies, is facing the challenge of a rapidly aging population. According to Singapore government data, the proportion of the population aged 65 and above continues to rise, and the incidence of age-related cognitive disorders (dementia) is also significant. The Singapore government is actively promoting nationwide initiatives such as the "Healthier SG" plan and the "Dementia-Friendly Singapore" project, encouraging early screening and full-cycle health management, which provides a favorable policy environment and market foundation for digital therapeutic products targeting cognitive disorders.
As a pioneer in China's cognitive digital therapeutics market, the company's core product, the "Brain Function Information Management Platform Software System," is the first digital therapeutic product for cognitive disorders approved by Chinese regulators. It has already been included in the provincial medical insurance reimbursement catalogs of 30 provinces in China. Natural Health Solutions is a professional health management service provider headquartered in Singapore, possessing its self-developed SC Health AI digital health assessment system, with a service network covering the community healthcare and health management markets.
According to the agreement, the collaboration primarily includes the following aspects: (I) Product Promotion Cooperation: The company will be responsible for the localization adaptation, system implementation, and personnel training support for its cognitive digital therapeutics products in Singapore; Natural Health Solutions will leverage its entire network of physical stores and member resources to target and recommend the company's products to potential users, managing the full service process including product introduction, trial guidance, purchase conversion, and after-sales support. (II) Market Expansion Synergy: Both parties will integrate resources in products, channels, brand, and technology to jointly develop the Singapore market, focusing on promoting the entry of the company's products into leading private and public hospital systems in Singapore, thereby enhancing the product's application and adoption within the local healthcare system.
The Board of Directors believes that this cooperation will bring long-term development opportunities for the company and create sustainable value for shareholders. Specifically: (I) Deepening International Layout and Expanding Overseas Markets: The company has already initiated product promotion and operations in Hong Kong and Macau, China, accumulating preliminary overseas market experience. This cooperation with Natural Health Solutions marks the official launch of the company's market presence and business development in the Southeast Asia region. This move will help systematically export the digital therapeutics experience and technological systems accumulated in the Chinese market to other regional markets with scale and policy support, further expanding the company's brand influence and business coverage internationally and enhancing its global footprint. (II) Enhancing Brand Influence and Commercial Network: This cooperation further strengthens the company's brand authority and professional image in the field of digital healthcare. By leveraging Natural Health Solutions's health management network in Singapore, the company can accelerate the deployment of its products in local medical institutions, shorten the market entry cycle, and expand into diverse markets such as digital health management.
Comments